Drug Trial Radar · NCT01624662
Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device
Last checked: Nov 19, 2026Latest source record: Dec 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
323
Actual
Start
Oct 30, 2013
Primary completion
May 11, 2015
Study completion Jul 3, 2015
Sponsor
- Lead sponsor
- Optinose US Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 21, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study was to compare the efficacy of intranasal administration of 100, 200, and 400 μg twice daily (bid) of fluticasone propionate, delivered by the Optinose device, with matching placebo in subjects with bilateral nasal polyposis and nasal congestion.
Conditions
- Bilateral Nasal Polyposis
Interventions
Fluticasone propionateDrug
Delivered via Optinose Exhalation Delivery System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in 7-day Average Instantaneous Morning Diary Congestion/Obstruction SymptomsTime frame: Baseline, Week 4 of the double-blind treatment phase
- Change in Total Polyp GradeTime frame: Baseline, Week 16 of the double-blind treatment phase
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Bensch Clinical Research LLC
Stockton, California
Colorado Allergy & Asthma Centers, PC
Centennial, Colorado
Advanced ENT and Allergy
Louisville, Kentucky
Institute for Asthma and Allergy
Wheaton, Maryland
Atlantic Research Center, LLC
Ocean City, New Jersey
Allergy and Asthma Research Group
Eugene, Oregon
Baker Allergy, Asthma and Dermatology Research Center, LLC
Lake Oswego, Oregon
Valley Clinical Research Center
Bethlehem, Pennsylvania
University of Vermont
Burlington, Vermont
Bellingham Asthma, Allergy, and Immunology Clinic
Bellingham, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.